Author

E. D. Di Brizzi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Metabolomic signatures associated with probiotic use in atopic dermatitis: An exploratory study.

Atopic dermatitis (AD) is a chronic inflammatory skin disorder modulated by complex interactions between immune dysregulation and compromised skin-barrier integrity, in which the gut microbiome may play a role in the natural course of the disease. Therefore, by influencing the composition of the gut microbiome, one of...

M. Salvatore, Angela Maione, E. D. Di Brizzi et al. · Journal of Pharmaceutical an... · 0 citations

Open access Sep 2026

Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis).

INTRODUCTION Conventional Psoriasis Area and Severity Index (PASI) response rates provide a cross-sectional assessment of treatment effectiveness but do not capture the speed, magnitude, and persistence of clinical improvement. This study evaluated the patient-level cumulative clinical benefit of brodalumab over 52 wee...

L. Potestio, S. Corrao, L. Mastorino et al. · Dermatologic Therapy · 0 citations

Open access Aug 2026

Targeting polymicrobial skin infections in atopic dermatitis: role of Pichia kudriavzevii postbiotics as innovative tools for human health

Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with microbial dysbiosis and persistent biofilm-forming infections, particularly involving Candida parapsilosis and Staphylococcus aureus. Postbiotics have recently emerged as promising alternatives to live probiotics due to their stability, safe...

Angela Maione, Annalisa Buonanno, Lea Di Massa et al. · Frontiers in Microbiology · 0 citations